Veteran investment executive focused on growth-stage healthcare and tech opportunities, with operating experience in corporate strategy and M&A. Melissa Imbrogno brings experience across private equity, corporate development and portfolio company leadership, often leading due diligence, operational improvement programs and capital raises. Market-facing profile: active deal leader, board observer and strategic operator supporting scaling and exits.
Veteran investment executive focused on growth-stage healthcare and tech opportunities, with operating experience in corporate strategy and M&A. Melissa Imbrogno brings experience across private equity, corporate development and portfolio company leadership, often leading due diligence, operational improvement programs and capital raises. Market-facing profile: active deal leader, board observer and strategic operator supporting scaling and exits.
Focuses on growth-stage healthcare and technology companies where operational intervention accelerates scale and exit value. Prefers equity-led primers and control/minority positions that enable active board or operator influence, prioritizing durable revenue models, differentiated clinical or tech moats, and capital-efficient commercialization pathways. Investment cadence balances rigorous due diligence, hands-on post-close operational improvement and targeted follow-on capital to de-risk milestones over a 3–7 year horizon with disciplined downside protection and exit orientation.
Focuses on growth-stage healthcare and technology companies where operational intervention accelerates scale and exit value. Prefers equity-led primers and control/minority positions that enable active board or operator influence, prioritizing durable revenue models, differentiated clinical or tech moats, and capital-efficient commercialization pathways. Investment cadence balances rigorous due diligence, hands-on post-close operational improvement and targeted follow-on capital to de-risk milestones over a 3–7 year horizon with disciplined downside protection and exit orientation.
| Trades 1142 | Longs Won 845/1142 73% | Profit Factor 13.56 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $380,696.67 |
| Average Win $124,490.78 | Best Trade (Aug 14) $6.21M | Sharpe Ratio -72.36 |
| Average Loss -$26,123.88 | Worst Trade (Aug 17) -$630,792.55 | Z-Score 13.85 (100%) |
| Commissions $0 | Avg. Trade Length 1y 1m 3w 4d | Expectancy $85,320.41 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 17,241 | 15,517 | 13,793 | 12,069 | 10,345 | 8,621 | 6,897 | 5,172 | 3,448 | 1,724 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAOI Applied Optoelectronics, Inc. | 3,505 | $296,488.08 | $330,591.6 | - | $34,103.52 | 11.5% | +4.672% |
AAPL Apple Inc. | 19,963 | $4.51M | $6.17M | - | $1.66M | 36.69% | -7.354% |
ABBV AbbVie Inc. | 1,722 | $370,152.3 | $432,118.68 | - | $61,966.38 | 16.74% | -2.513% |
ACEI Innovator Equity Accelerated Income Strategy ETF | 14,488 | $335,336 | $330,036.64 | - | -$5,299.36 | -1.58% | -0.044% |
ACII Innovator Index Autocallable Income ETF | 13,925 | $354,391 | $353,555.75 | - | -$835.25 | -0.24% | -0.431% |
AIQ Global X Artificial Intelligence & Technology ETF | 99,007 | $5.41M | $5.83M | - | $420,681.52 | 7.78% | +0.341% |
ALT Altimmune, Inc. | 236,136 | $1.17M | $670,626.24 | - | -$494,397.79 | -42.44% | -4.698% |
AMAT Applied Materials, Inc. | 428 | $309,444 | $217,282.76 | - | -$92,161.24 | -29.78% | +1.176% |
AMD Advanced Micro Devices, Inc. | 1,266 | $267,435.29 | $602,805.89 | - | $335,370.6 | 125.4% | -1.904% |
AMZN Amazon.com Inc | 8,557 | $1.51M | $2.32M | - | $809,752.35 | 53.48% | +15.321% |
AVGO Broadcom Inc. | 2,993 | $849,950.15 | $1.17M | - | $315,164.89 | 37.08% | +0.371% |
BALT Inn Defined Wealth Shield Mutual Fund | 155,832 | $4.88M | $5.37M | - | $483,568.5 | 9.9% | +0.175% |
BIV Vanguard Intermediate-Term Bond ETF (likely mapping for ticker 0V1L) | 388,428 | $29.82M | $29.34M | - | -$476,404.52 | -1.6% | -0.198% |
BNDX Vanguard Total International Bond ETF | 148,195 | $7.16M | $7.08M | - | -$79,622.92 | -1.11% | -0.23% |
BRBR BellRing Brands Inc. | 14,128 | $159,222.56 | $175,045.92 | - | $15,823.36 | 9.94% | -5.779% |
BRK-B Berkshire Hathaway Inc. | 1,128 | $562,754.37 | $577,017.12 | - | $14,262.75 | 2.53% | +0.365% |
CAIE Calamos Autocallable Income ETF | 7,813 | $208,789.09 | $209,857.18 | - | $1,068.09 | 0.51% | +0.562% |
CAT Caterpillar Inc. | 454 | $235,782.64 | $369,923.74 | - | $134,141.1 | 56.89% | +0.701% |
CHAT Roundhill Generative AI & Technology ETF | 4,270 | $261,556.74 | $349,969.2 | - | $88,412.46 | 33.8% | +2.22% |
CIFR Cipher Mining Inc. | 8,536 | $209,132 | $190,523.52 | - | -$18,608.48 | -8.9% | -1.479% |